Healthcare reform has been in the news a lot lately, with constant finger-pointing, debate, and competing versions of comprehensive bills. Although the passage of comprehensive reform appears to be less certain that it was only weeks ago, it remains likely that major changes are coming before the end of the year. While many specifics are still up in the air, it is becoming clear that the outcome of this issue could make a major impact from Main Street to Wall Street. So what does all the speculation and proposed reform mean for healthcare ETFs? That all depends on which of the three main types of funds you’re talking about; biotech ETFs, pharmaceutical ETFs, and healthcare provider ETFs each figure to be impacted in a unique manner as this saga plays out. Each comes complete with its own risks and rewards for investing at a tumultuous time in this rapidly-changing industry. [click to continue…]
{ Comments on this entry are closed }
